Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Current Drug Targets|February 10, 2009
Anti-CD30 human IL-2 fusion proteins display strong and specific cytotoxicity in vivoB Hirsch, J Brauer, M Fischdick, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2000
The HTLV-I tax protein transcriptionally modulates OX40 antigen expressionR Pankow, H Dürkop, U Latza, et al.
Nature Medicine|October 23, 1997
Interleukin-15 protects from lethal apoptosis in vivoS Bulfone-Paus, D Ungureanu, T Pohl, et al.
The Journal of Clinical Investigation|March 1, 1996
Suppression of cell-mediated and humoral immune responses by an interleukin-2-immunoglobulin fusion protein in miceU Kunzendorf, T Pohl, S Bulfone-Paus, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2000
Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasis?R Rückert, K Asadullah, M Seifert, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 27, 1999
Death deflected: IL-15 inhibits TNF-alpha-mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL-15Ralpha chainS Bulfone-Paus, E Bulanova, T Pohl, et al.
The Journal of Pathology|September 27, 2000
The restricted expression pattern of the Hodgkin's lymphoma-associated cytokine receptor CD30 is regulated by a minimal promoterH Dürkop, M Oberbarnscheidt, U Latza, et al.
Pageof 5